financetom
Business
financetom
/
Business
/
Reko International Group Up Near 3.5% As Forex Losses Impact Its Q1 FY25 Earnings; But Signs of Improvement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reko International Group Up Near 3.5% As Forex Losses Impact Its Q1 FY25 Earnings; But Signs of Improvement
Dec 5, 2024 1:19 PM

03:50 PM EST, 12/05/2024 (MT Newswires) -- Reko International Group ( RKIGF ) , a diversified, technology-driven manufacturing company, was at last look trading up near 3.5% from 52 week low levels on Thursday even as it reported a drop in basis earnings per share for the first quarter of its fiscal 2025 year on lower revenues. But it pointed to foreign exchange losses impacting earnings in the latest Q1, while it cited lower sales recognition and lower overall backlog as factors impacting revenues.

Net earnings for the quarter ended October 31, 2024, were $88,000, or $0.02 per share, compared to $311,000, or $0.05 per share, in the same quarter last year. It said the latest quarter includes a year over year net foreign exchange loss of $544,000, or $0.10 per share. Excluding this, earnings improved by $0.07 per share compared to the prior year.

Consolidated sales for the quarter decreased by 25.3% to $10.238 million compared to the same period last year. It said sales in certain areas of the business are influenced by the number of active projects, the value of awards, and the timing of project milestones, which can vary significantly by job, sector and by customer. During the first quarter, a higher proportion of projects were at earlier stages of completion, contributing to lower sales recognition relative to the previous year. Additionally, while project kick-offs from automotive customers showed some improvement compared to the latter half of fiscal 2024, the overall backlog at the start of this fiscal year was lower than at the beginning of the previous year in that sector.

Of note, the company said quarterly net income improved by $3.547 million and $0.64 per share over the fourth quarter of the prior fiscal year. Reko had an improved cash position of $2.4 million over prior quarter and $6.1 million over first quarter of fiscal 2024.

"This quarter's performance highlights meaningful progress, with improved financial results compared to recent quarters," said CEO Diane Reko. "These results indicate that our strategic initiatives are beginning to translate into financial gains, and we are confident this momentum will continue. We remain committed to driving growth through operational excellence and expanding into high-opportunity markets."

Price: 3.00, Change: +0.10, Percent Change: +3.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla quarterly deliveries decline for the first time in nearly four years
Tesla quarterly deliveries decline for the first time in nearly four years
Apr 2, 2024
(Reuters) - Tesla on Tuesday posted a decline in quarterly deliveries for the first time in nearly four years and missed Wall Street estimates, a performance some described as ugly as price cuts failed to stir demand in a highly competitive market. Shares of the Elon Musk-led company were down 5.3% at $165.98 at midday on Tuesday, losing about $30...
Why VivoPower International Stock (VVPR) Is Up Over 300%
Why VivoPower International Stock (VVPR) Is Up Over 300%
Apr 2, 2024
VivoPower International PLC ( VVPR ) shares are trading higher by 323% to $6.18 during Tuesday’s session after the company’s Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited. VivoPower ( VVPR ) says the agreement entails exclusive negotiations for a business combination to merge with CCTS, with Tembo surviving the merger and changing its...
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
Apr 2, 2024
(Reuters) - Four doses of Eli Lilly's ( LLY ) diabetes drug Mounjaro would remain in tight supply through 2024 due to soaring demand, the U.S. Food and Drug Administration's website showed. The regulator noted limited availability of 7.5, 10, 12.5, and 15 milligram doses through April, while lower doses were listed as available. The FDA had previously said that...
What's Going On With Sutro Biopharma (STRO) Stock?
What's Going On With Sutro Biopharma (STRO) Stock?
Apr 2, 2024
Sutro Biopharma Inc ( STRO ) shares are trading lower by 2.8% to $5.18 during Tuesday’s session after the company announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at $5.18 per share, aiming to raise approximately $75 million. The offering, expected to close around April 4, involves all shares being offered by Sutro and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved